Press Center
-
February 16, 2024Harrow, Inc., a leading U.S. eyecare pharmaceutical company, and Apotex Inc., Canada’s largest pharmaceutical company, today jointly announced an exclusive out-licensing agreement under which Apotex will market and distribute VERKAZIA® and over-the-counter (OTC) Cationorm® PLUS in the Canadian market, and concurrently, pursue market approval in Canada for VEVYE®, IHEEZO®, and ZERVIATE®.
-
November 21, 2023
-
September 5, 2023
-
April 26, 2023
-
April 19, 2023
-
March 1, 2023
-
April 12, 2022
-
January 19, 2022
-
December 7, 2021
-
October 7, 2021
-
March 31, 2021
-
December 2, 2020
-
June 5, 2020
-
May 27, 2020
-
May 7, 2020
-
September 25, 2019